The development of cortical beta-adrenoceptor subsensitivity in the rat by chronic treatment with trazodone, doxepin and mianserine.
D000526:Alprenolol / Q000031:analogs & derivatives / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism; D003984:Dibenzazepines / Q000494:pharmacology*; D004316:Doxepin / Q000494:pharmacology*; D008297:Male; D008566:Membranes / Q000187:drug effects / Q000378:metabolism; D008803:Mianserin / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology*; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects* / Q000378:metabolism; D013997:Time Factors; D014196:Trazodone / Q000494:pharmacology*
D003984:Dibenzazepines; D010879:Piperazines; D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta; D004316:Doxepin; D008803:Mianserin; D000526:Alprenolol; D014196:Trazodone